Low prevalence of patients with mitochondrial disease in the German/Austrian DPV diabetes registry
- 15 December 2015
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 175 (5) , 613-622
Abstract
The aim of this study was to characterize the phenotype and treatment of young patients (manifestation n = 5), Pearson (n = 3), or mitochondrial myopathy, encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome (n = 2). The onset of DMO (14.2, interquartile range (IQR) 7.1–16 years) was later than diabetes onset in individuals with T1D but earlier than in T2D. At manifestation, patients exhibited a mild elevation of blood glucose concentrations (251, IQR 178–299 mg/dl) without ketoacidosis. They had lower body mass index (BMI) values (−1.39 ± 0.28 kg/m2) than peers with T1D or T2D (p < 0.0001) and higher triglycerides (211, IQR 134–574 mg/dl) than in T1D (p = 0.04) while there was a high rate of dyslipidemia (86 %). Insulin requirements (0.58, IQR 0.37–0.90 U/kg/d) were between T1D and T2D while glucometabolic control (glycated hemoglobin A1c (HbA1c) 7.4 ± 0.52 %) in DMO was comparable to age-matched T2D and stable over a 5-year follow-up. Conclusion: Primary mitochondrial disorders are a rare cause of juvenile diabetes and likely to be underdiagnosed. As there is clinical overlap with T1D and T2D, dyslipidemia and low body weight may help to identify further DMO cases. What is Known: • In adults diabetes of mitochondrial origin (DMO) is a rare cause of non-autoimmune diabetes, affecting about 0.8 % of diabetes cases. • Common features are a maternal family history of diabetes, hearing loss and neurological abnormalities. What is New: • In our juvenile cohort 0.02 % of diabetes patients (age < 30 years) were affected by DMO, while Kearns Sayre, MELAS and Pearson syndrome were the most frequent entities. • Juvenile DMO patients exhibited dyslipidemia, higher triglycerides and a lower BMI than peers with T1D or T2D, while some patients also showed retinal changes.Keywords
Funding Information
- German Federal Ministry of Education and Research (BMBF) for the Competence Network for Diabetes mellitus (Kompetenznetz Diabetes mellitus) (FKZ 01GI1106)
- German Center for Diabetes Research (DZD)
- German Diabetes Association (Deutsche Diabetes Gesellschaft, DDG)
- European Foundation for the Study of Diabetes (DE)
- Heinz Bürger-Büsing foundation
This publication has 43 references indexed in Scilit:
- Endocrine disorders in mitochondrial diseaseMolecular and Cellular Endocrinology, 2013
- Mitochondrial Diabetes in Children: Seek and You Will Find ItPLOS ONE, 2012
- Insulin Therapy to Improve BMI in Cystic Fibrosis–Related Diabetes Without Fasting HyperglycemiaDiabetes Care, 2009
- Impaired Mitochondrial Function and Insulin Resistance of Skeletal Muscle in Mitochondrial DiabetesDiabetes Care, 2009
- Is mitochondrial dysfunction a cause of insulin resistance?Trends in Endocrinology & Metabolism, 2008
- Presentation and Diagnosis of Mitochondrial Disorders in ChildrenPediatric Neurology, 2008
- Metabolic control as reflectet by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decadeEuropean Journal of Pediatrics, 2007
- Kearns Sayre syndrome: an unusual form of mitochondrial diabetesDiabetes & Metabolism, 2006
- Perzentile für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher StichprobenMonatsschrift Kinderheilkunde, 2001
- Level of heteroplasmy for the mitochondrial mutation A3243G correlates with age at onset of diabetes and deafnessHuman Mutation, 1998